3-10142116-A-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000551.4(VHL):c.269A>T(p.Asn90Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N90S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000551.4 missense
Scores
Clinical Significance
Conservation
Publications
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
 - von Hippel-Lindau diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet
 - renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - autosomal recessive secondary polycythemia not associated with VHL geneInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
 - Chuvash polycythemiaInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
 - hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| VHL | NM_000551.4  | c.269A>T | p.Asn90Ile | missense_variant | Exon 1 of 3 | ENST00000256474.3 | NP_000542.1 | |
| VHL | NM_001354723.2  | c.269A>T | p.Asn90Ile | missense_variant | Exon 1 of 3 | NP_001341652.1 | ||
| VHL | NM_198156.3  | c.269A>T | p.Asn90Ile | missense_variant | Exon 1 of 2 | NP_937799.1 | ||
| VHL | NR_176335.1  | n.339A>T | non_coding_transcript_exon_variant | Exon 1 of 4 | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 33 
GnomAD4 exome Cov.: 32 
GnomAD4 genome  Cov.: 33 
ClinVar
Submissions by phenotype
Von Hippel-Lindau syndrome    Pathogenic:1 
- -
Hereditary cancer-predisposing syndrome    Pathogenic:1 
The p.N90I variant (also known as c.269A>T), located in coding exon 1 of the VHL gene, results from an A to T substitution at nucleotide position 269. The asparagine at codon 90 is replaced by isoleucine, an amino acid with dissimilar properties. This variant has been reported in multiple Asian families diagnosed with VHL (Yoshida M et al. Jpn. J Cancer Res. 2000 Feb;91:204-12; Wu P et al. J Hum Genet. 2012 Apr;57(4):238-43; Sousa AL et al. World J Gastrointest Endosc. 2013 Oct 16;5(10):519-22; Ning XH et al. Cancer Res. 2014 Jul 15;74(14):3802-9; Hong B et al. Front Genet. 2019 Sep 18;10:867). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at